Accuray (ARAY) Net Margin (2010 - 2026)
Accuray posted quarterly Net Margin of 11.26% for Q1 2026, down 1011.0% year-on-year from 1.24% in Q1 2025, and up 16.4% on a QoQ basis from 13.47% in Q4 2025.
Accuray (ARAY) has 17 years of Net Margin data on file, last reported at 11.26% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 1011.0% year-over-year to 11.26%; the trailing twelve-month figure through Mar 2026 stood at 12.99% (down 1360.0% YoY), and the FY2025 full-year result was 0.35%, up 313.0% from the prior year.
- Net Margin for Q1 2026 stood at 11.26%, up from 13.47% in the prior quarter.
- Across five years, Net Margin topped out at 28.2% in Q2 2025 and bottomed at 23.08% in Q3 2025.
- The 5-year median for Net Margin is 1.63% (2022), against an average of 1.8%.
- The widest annual swing landed in 2023, when Net Margin slumped 1967 bps; it then surged 2348 bps in 2024.
- A 5-year view of Net Margin shows it stood at 1.63% in 2022, then slumped by 1204 bps to 21.3% in 2023, then soared by 110 bps to 2.18% in 2024, then slumped by 717 bps to 13.47% in 2025, then rose by 16 bps to 11.26% in 2026.
- The last three Net Margin figures came in at 11.26% (Q1 2026), 13.47% (Q4 2025), and 23.08% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn | -11.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.26% |
| Dec 31, 2025 | -13.47% |
| Sep 30, 2025 | -23.08% |
| Jun 30, 2025 | 28.20% |
| Mar 31, 2025 | -1.15% |
| Dec 31, 2024 | 2.18% |
| Sep 30, 2024 | -3.89% |
| Jun 30, 2024 | 22.21% |
| Mar 31, 2024 | -6.27% |
| Dec 31, 2023 | -21.30% |
| Sep 30, 2023 | -13.22% |
| Jun 30, 2023 | 18.25% |
| Mar 31, 2023 | 0.51% |
| Dec 31, 2022 | -1.63% |
| Sep 30, 2022 | -22.72% |
| Jun 30, 2022 | 17.19% |
| Mar 31, 2022 | -1.09% |
| Dec 31, 2021 | 0.15% |
| Sep 30, 2021 | -12.66% |
| Jun 30, 2021 | 30.51% |
| Mar 31, 2021 | -0.38% |
| Dec 31, 2020 | 4.89% |
| Sep 30, 2020 | 0.47% |
| Jun 30, 2020 | 51.37% |
| Mar 31, 2020 | 2.64% |
| Dec 31, 2019 | 10.84% |
| Sep 30, 2019 | -10.44% |
| Jun 30, 2019 | -1.27% |
| Mar 31, 2019 | -1.15% |
| Dec 31, 2018 | -4.53% |
| Sep 30, 2018 | -9.61% |
| Jun 30, 2018 | -0.83% |
| Mar 31, 2018 | -8.87% |
| Dec 31, 2017 | -4.70% |
| Sep 30, 2017 | -10.32% |
| Jun 30, 2017 | -4.69% |
| Mar 31, 2017 | -5.17% |
| Dec 31, 2016 | -10.71% |
| Sep 30, 2016 | -11.47% |
| Jun 30, 2016 | -7.59% |
| Mar 31, 2016 | 0.72% |
| Dec 31, 2015 | -5.53% |
| Sep 30, 2015 | -14.53% |
| Jun 30, 2015 | -5.50% |
| Mar 31, 2015 | -3.04% |
| Dec 31, 2014 | -10.18% |
| Sep 30, 2014 | -26.28% |
| Jun 30, 2014 | -9.62% |
| Mar 31, 2014 | -4.80% |
| Dec 31, 2013 | -5.81% |
| Sep 30, 2013 | -20.27% |
| Jun 30, 2013 | -22.04% |
| Mar 31, 2013 | -44.23% |
| Dec 31, 2012 | -37.50% |
| Sep 30, 2012 | -29.16% |
| Jun 30, 2012 | -20.16% |
| Mar 31, 2012 | -14.62% |
| Dec 31, 2011 | -9.76% |
| Sep 30, 2011 | -26.39% |
| Jun 30, 2011 | -225.05% |
| Mar 31, 2011 | -2.12% |
| Dec 31, 2010 | 7.55% |
| Sep 30, 2010 | -12.19% |